David Tscharke
David Tscharke
John Curtin School of Medical Research, Australian National University
Verified email at anu.edu.au - Homepage
Title
Cited by
Cited by
Year
The developmental pathway for CD103+ CD8+ tissue-resident memory T cells of skin
LK Mackay, A Rahimpour, JZ Ma, N Collins, AT Stock, ML Hafon, ...
Nature immunology 14 (12), 1294-1301, 2013
6462013
A consensus epitope prediction approach identifies the breadth of murine T CD8+-cell responses to vaccinia virus
M Moutaftsi, B Peters, V Pasquetto, DC Tscharke, J Sidney, HH Bui, ...
Nature biotechnology 24 (7), 817-819, 2006
4442006
CD8+ T cell cross-priming via transfer of proteasome substrates
CC Norbury, S Basta, KB Donohue, DC Tscharke, MF Princiotta, ...
Science 304 (5675), 1318-1321, 2004
3322004
Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines
DC Tscharke, G Karupiah, J Zhou, T Palmore, KR Irvine, SM Haeryfar, ...
Journal of Experimental Medicine 201 (1), 95-104, 2005
3222005
Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons.
A Simmons, DC Tscharke
The Journal of experimental medicine 175 (5), 1337-1344, 1992
2651992
Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes
E Assarsson, JA Greenbaum, M Sundström, L Schaffer, JA Hammond, ...
Proceedings of the National Academy of Sciences 105 (6), 2140-2145, 2008
1672008
Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes
DC Tscharke, PC Reading, GL Smith
Journal of General Virology 83 (8), 1977-1986, 2002
1462002
HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation
C Oseroff, F Kos, HH Bui, B Peters, V Pasquetto, J Glenn, T Palmore, ...
Proceedings of the National Academy of Sciences 102 (39), 13980-13985, 2005
1432005
Regulatory T cells suppress CD8+ T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities
SMM Haeryfar, RJ DiPaolo, DC Tscharke, JR Bennink, JW Yewdell
The Journal of Immunology 174 (6), 3344-3351, 2005
1402005
The vaccinia virus N1L protein is an intracellular homodimer that promotes virulenceAccession numbers for the vaccinia virus N1L genes are: VV strain Western Reserve, AF451287 …
N Bartlett, JA Symons, DC Tscharke, GL Smith
Journal of General Virology 83 (8), 1965-1976, 2002
1382002
A study of the vaccinia virus interferon-γ receptor and its contribution to virus virulence
JA Symons, DC Tscharke, N Price, GL Smith
Journal of General Virology 83 (8), 1953-1964, 2002
1302002
Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB/c mice
DC Tscharke, WP Woo, IG Sakala, J Sidney, A Sette, DJ Moss, ...
Journal of virology 80 (13), 6318-6323, 2006
1222006
Kinetics of antigen expression and epitope presentation during virus infection
NP Croft, SA Smith, YC Wong, CT Tan, NL Dudek, IEA Flesch, LCW Lin, ...
PLoS Pathog 9 (1), e1003129, 2013
1192013
A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae
DC Tscharke, GL Smith
Journal of General Virology 80 (10), 2751-2755, 1999
1191999
Local proliferation maintains a stable pool of tissue-resident memory T cells after antiviral recall responses
SL Park, A Zaid, JL Hor, SN Christo, JE Prier, B Davies, YO Alexandre, ...
Nature immunology 19 (2), 183-191, 2018
1172018
Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara
CL Smith, F Mirza, V Pasquetto, DC Tscharke, MJ Palmowski, PR Dunbar, ...
The Journal of Immunology 175 (12), 8431-8437, 2005
1072005
HLA-A* 0201, HLA-A* 1101, and HLA-B* 0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products
V Pasquetto, HH Bui, R Giannino, F Mirza, J Sidney, C Oseroff, ...
The Journal of Immunology 175 (8), 5504-5515, 2005
1042005
Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy
RH Clark, JC Kenyon, NW Bartlett, DC Tscharke, GL Smith
Journal of general virology 87 (1), 29-38, 2006
982006
The role of immune mechanisms in control of herpes simplex virus infection of the peripheral nervous system
A Simmons, D Tscharke, P Speck
Herpes Simplex Virus, 31-56, 1992
941992
The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence
A Ng, DC Tscharke, PC Reading, GL Smith
Journal of General Virology 82 (9), 2095-2105, 2001
902001
The system can't perform the operation now. Try again later.
Articles 1–20